<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd"
xmlns:rawvoice="http://www.rawvoice.com/rawvoiceRssModule/"
	>
<channel>
	<title>Comments on: AGs Feel Chest Pains Over Generic TriCor</title>
	<atom:link href="http://www.patentbaristas.com/archives/2008/03/21/ags-feel-chest-pains-over-generic-tricor/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.patentbaristas.com/archives/2008/03/21/ags-feel-chest-pains-over-generic-tricor/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=ags-feel-chest-pains-over-generic-tricor</link>
	<description>Freshly Brewed Bio/Pharma Chat. Served Up Daily.</description>
	<lastBuildDate>Tue, 07 Feb 2012 11:57:58 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
	<item>
		<title>By: Patent Baristas &#187; Trinko&#8217;s Twist: A New Antitrust Argument Against Product Hopping</title>
		<link>http://www.patentbaristas.com/archives/2008/03/21/ags-feel-chest-pains-over-generic-tricor/comment-page-1/#comment-65018</link>
		<dc:creator>Patent Baristas &#187; Trinko&#8217;s Twist: A New Antitrust Argument Against Product Hopping</dc:creator>
		<pubDate>Thu, 13 Nov 2008 17:27:46 +0000</pubDate>
		<guid isPermaLink="false">http://www.patentbaristas.com/archives/2008/03/21/ags-feel-chest-pains-over-generic-tricor/#comment-65018</guid>
		<description>[...] As of July 2008, twenty-five states and the District of Columbia have filed antitrust suits against Abbott Laboratories and Solvay’s Fournier Industrie et Santé and Laboratories Fournier in Delaware District Court, charging them with blocking generic competition by engaging in product hopping, among other &#8220;anti-generic strategies.&#8221;  Patent Baristas reported the initial filing here. [...]</description>
		<content:encoded><![CDATA[<p>[...] As of July 2008, twenty-five states and the District of Columbia have filed antitrust suits against Abbott Laboratories and Solvay’s Fournier Industrie et Santé and Laboratories Fournier in Delaware District Court, charging them with blocking generic competition by engaging in product hopping, among other &#8220;anti-generic strategies.&#8221;  Patent Baristas reported the initial filing here. [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Fenofibrate in the news (again) at Drug Kennel</title>
		<link>http://www.patentbaristas.com/archives/2008/03/21/ags-feel-chest-pains-over-generic-tricor/comment-page-1/#comment-53251</link>
		<dc:creator>Fenofibrate in the news (again) at Drug Kennel</dc:creator>
		<pubDate>Wed, 04 Jun 2008 13:22:48 +0000</pubDate>
		<guid isPermaLink="false">http://www.patentbaristas.com/archives/2008/03/21/ags-feel-chest-pains-over-generic-tricor/#comment-53251</guid>
		<description>[...] Recall that fenofibrate is a 30+ year-old drug.  Abbott introduced the product as a capsule.  Teva filed an ANDA and Abbott sued, triggering the 30-month stay.  During this stay, Abbott introduced a tablet version and withdrew the capsules, nullifying Teva&#8217;s generic.  Teva then filed an ANDA for the tablets.  Abbott sued, again triggering the 30-month stay during which it changed the dose, nullifying, once again, Teva&#8217;s generic.  Teva enlisted 25* state attorneys general to file a suit in federal court in Delaware alleging that Abbott has illegally used &#8220;product switching&#8221; to avoid generic competition.  A more legal-based review is here. [...]</description>
		<content:encoded><![CDATA[<p>[...] Recall that fenofibrate is a 30+ year-old drug.  Abbott introduced the product as a capsule.  Teva filed an ANDA and Abbott sued, triggering the 30-month stay.  During this stay, Abbott introduced a tablet version and withdrew the capsules, nullifying Teva&#8217;s generic.  Teva then filed an ANDA for the tablets.  Abbott sued, again triggering the 30-month stay during which it changed the dose, nullifying, once again, Teva&#8217;s generic.  Teva enlisted 25* state attorneys general to file a suit in federal court in Delaware alleging that Abbott has illegally used &#8220;product switching&#8221; to avoid generic competition.  A more legal-based review is here. [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Ken Phelps</title>
		<link>http://www.patentbaristas.com/archives/2008/03/21/ags-feel-chest-pains-over-generic-tricor/comment-page-1/#comment-53246</link>
		<dc:creator>Ken Phelps</dc:creator>
		<pubDate>Wed, 04 Jun 2008 12:33:37 +0000</pubDate>
		<guid isPermaLink="false">http://www.patentbaristas.com/archives/2008/03/21/ags-feel-chest-pains-over-generic-tricor/#comment-53246</guid>
		<description>Re: 505(b)(1) or (b)(2), Abbott licensed the product from Laboratories Fournier.  Thus, Abbott had the rights to the data, making this a (b)(1).  as Stephen indicates, a (b)(2) is used when data that is needed for approval is not owned by the applicant.
For 505(b)(2) fans, this saga provides instructive support to the idea that small changes to an innovator product a) can be patented and b) can have a healthy market.</description>
		<content:encoded><![CDATA[<p>Re: 505(b)(1) or (b)(2), Abbott licensed the product from Laboratories Fournier.  Thus, Abbott had the rights to the data, making this a (b)(1).  as Stephen indicates, a (b)(2) is used when data that is needed for approval is not owned by the applicant.<br />
For 505(b)(2) fans, this saga provides instructive support to the idea that small changes to an innovator product a) can be patented and b) can have a healthy market.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: generic of tricor</title>
		<link>http://www.patentbaristas.com/archives/2008/03/21/ags-feel-chest-pains-over-generic-tricor/comment-page-1/#comment-50874</link>
		<dc:creator>generic of tricor</dc:creator>
		<pubDate>Wed, 14 May 2008 03:16:18 +0000</pubDate>
		<guid isPermaLink="false">http://www.patentbaristas.com/archives/2008/03/21/ags-feel-chest-pains-over-generic-tricor/#comment-50874</guid>
		<description>[...] Over generic tricor &amp;8221 ... pdfAGs Feel Chest Pains Over generic tricor - Patent BaristasThe ...http://www.patentbaristas.com/archives/2008/03/21/ags-feel-chest-pains-over-generic-tricorPro-Life Doctors Need Not Apply Are we advancing or regressing as a culture? abilify price accutane [...]</description>
		<content:encoded><![CDATA[<p>[...] Over generic tricor &#38;8221 &#8230; pdfAGs Feel Chest Pains Over generic tricor &#8211; Patent BaristasThe &#8230;<a href="http://www.patentbaristas.com/archives/2008/03/21/ags-feel-chest-pains-over-generic-tricorPro-Life" rel="nofollow">http://www.patentbaristas.com/archives/2008/03/21/ags-feel-chest-pains-over-generic-tricorPro-Life</a> Doctors Need Not Apply Are we advancing or regressing as a culture? abilify price accutane [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: anonymous</title>
		<link>http://www.patentbaristas.com/archives/2008/03/21/ags-feel-chest-pains-over-generic-tricor/comment-page-1/#comment-47878</link>
		<dc:creator>anonymous</dc:creator>
		<pubDate>Fri, 11 Apr 2008 14:50:04 +0000</pubDate>
		<guid isPermaLink="false">http://www.patentbaristas.com/archives/2008/03/21/ags-feel-chest-pains-over-generic-tricor/#comment-47878</guid>
		<description>Thanks Stephen for your so quick response, I apperecite it!I was wondeering how does one get to know that the filling was a 505 b ..is there any pointer to that in fda site or orange book?
thanks again</description>
		<content:encoded><![CDATA[<p>Thanks Stephen for your so quick response, I apperecite it!I was wondeering how does one get to know that the filling was a 505 b ..is there any pointer to that in fda site or orange book?<br />
thanks again</p>
]]></content:encoded>
	</item>
</channel>
</rss>

<!-- Performance optimized by W3 Total Cache. Learn more: http://www.w3-edge.com/wordpress-plugins/

Served from: www.patentbaristas.com @ 2012-02-12 18:02:13 -->
